Letters to the Editor

Rae-Grant Q . Millennium—fantasy, furor, and fact [editorial]. Can J Psychiatry 1999;44:18.

Pakes EH . Death of a child. In: Steinhauer P Rae-Grant Q , editors. Psychological problems of the child and his family. 1980. Revised, 1983.

Freud S . 1900. The interpretation of dreams. Hogarth Press; 1953

Pollock GH . The mourning-liberation process. Madison (CT): International Universities Press; 1989

Bowman ML . Individual differences in posttraumatic distress: Problems with the DSM-IV model. Can J Psychiatry 1999;44:21–33.

Bowman ML . Individual differences in posttraumatic distress: Problems with the DSM-IV model. Can J Psychiatry 1999;44:21–33.

Sigal JJ Weinfeld M . Trauma and rebirth: Intergenerational effects of the Holocaust. New York: Praeger; 1989.

Eaton WW Sigal JJ Weinfeld M . Impairment in Holocaust survivors after 33 years: Data from an unbiased community sample. Am J Psychiatry 1982;139:773–7.

Kuch K Cox B . Symptoms of PTSD in 124 survivors of the Holocaust. Am J Psychiatry 1992;149:337–40.

Yehuda R . Biological factors associated with susceptibility to posttraumatic stress disorder. Can J Psychiatry 1999;44:34–9.

Ontario Government. Implementation planning guidelines for mental-health reform, Appendix B: p 19. Toronto: Queen's Printer for Ontario; 1994.

Butzlaff RL Hooley JM . Expressed emotion and psychiatric relapse: A metaanalysis. Arch Gen Psychiatry 1998;55:547–52.

Miklowitz DJ Goldstein MJ Nuechterlein KH Snyder KS Mintz J . Family factors and the course of bipolar affective disorder. Arch Gen Psychiatry 1988;45:225–31.

Baldessarini RJ . Drugs and the treatment of psychiatric disorders: Antimanic and antidepressant agents. In: Harden W Rudin W Molinoff PB , editors. Goodman and Gilman's the pharmacologic basis of therapeutics. New York: McGraw-Hill; 1996. p 431–59.

Rose RC Lane RM Menza M . Effects of SSRI's on sexual function: A critical review. J Clin Psychopharmacol 1999;19:67–85.

Ascher JA Col JO Colin JN Feighner JP Ferris RM , Fibiger HC, and others. Bupropion: A review of its mechanism of antidepressant activity. J Clin Psychiatry 1995;56:395–401.

Labatte LA Grimes JB Hines A Pollack MH . Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Ann Clin Psychiatry 1997;9:241–5.

Hayford KE Patten CA Rummans TA Schroeder DR Offord KP , Croghan IT, and others. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatry 1999;174:173–8.

Handley SL Dursun SM . Serotonin and Tourette's syndrome: Movements such as head-shakes and wet-dog shakes may model human tics. Advances in the Biosciences 1992;22:235–53.

Dursun SM Reveley MA Bird R Stirton RF . Long lasting improvement of Tourette syndrome with transdermal nicotine. Lancet 1994;344:1577.

Peterson BS Leckman JF Scahill L Naftolin F Keefe D Charest NJ Cohen DJ . Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome. Psychoneuroendocrinology 1992;17:553–63.

Leckman JF Scahill L . Possible exacerbation of tics by androgenic steroids [letter]. N Engl J Med 1990;322:1674.

Peterson BS Zhang H Anderson GM Leckman JF . A double-blind, placebo controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome. J Clin Psychoparmacol 1998;18:324–31.

Harcherik DF Leckman JF Detlor J Cohen DJ . A new instrument for clinical studies of Tourette's syndrome. J Am Acad Child Psychiatry 1984;23:153–60.

Leckman JF Riddle MA Hardin MT Ort SI Swartz KL , Stevenson J, and others. The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989;28:566–73.

Hughes J Hatsukami D Mitchell J Dahlgren L . Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 1986;143:993–7.

Tran PV Dellva MA Toffelson GD Beasley CM Jr Potvin JH Kiesler GM . Extrapyramidal symptoms and tolerability of olanzapine versus Haldol in the acute treatment of schizophrenia. J Clin Psychiatry 1997;58:205–11.

Burkhard PR Vingerhoets FJG . Olanzapine-induced neuroleptic malignant syndrome [letter]. Arch Gen Psychiatry 1999;56:101–2.

Chafteron R Cardy S Schramm M . Neuroleptic malignant syndrome and clozapine monotherapy: Response. Aust N Z J Psychiatry 1997;31:435–6.

Hasan S Buckley P . Novel antipsychotics and neuroleptic malignant syndrome: A review and critique. Am J Psychiatry 1998;155:1113–6.

Meltzer H Cola P Parsa M . Marked elevation of serum creatinine kinase activity associated with antipsychotic drug treatment. Neuropsychopharmacology 1996;15:395–405.

Lee JWY . Neuroleptic malignant syndrome and clozapine monotherapy: Comment [letter]. Aust N Z J Psychiatry 1997;31:435–6.

Goats MG Escobar JL . An apparent neuroleptic malignant syndrome without extrapyramidal symptoms upon initiation of a clozapine therapy: Report of a case and results of a clozapine rechallenge. J Clin Psychopharmacol 1992;12:139–40.